Evidence map›Paper›PMID 23623868›Full record

ReviewMolecular and cellular endocrinology2013

Nuclear receptors in inflammation control: repression by GR and beyond.

Yurii Chinenov, Rebecca Gupte, Inez Rogatsky

Open access · greenAbstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Glucocorticoid receptors: finding the middle ground.The Journal of clinical investigation · 2017
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yurii ChinenovHospital for Special Surgery, 535 East 70th Street, New York, NY 10021, United States.
Rebecca Gupte
Inez Rogatsky
Hospital for Special Surgery · USCornell University · US

Funding

Mechanisms of Immunosuppressive Actions of GlucocorticoidsR01AI068820 · NIAID · HOSPITAL FOR SPECIAL SURGERY · PI ROGATSKY, INEZ · 2007 to 2011
$2.3M
NIAID NIH HHS R01 AI068820
6 · The paper itself

Abstract

Inflammation is a protective response of organisms to pathogens, irritation or injury. Primary inflammatory sensors activate an array of signaling pathways that ultimately converge upon a few transcription factors such as AP1, NFκB and STATs that in turn stimulate expression of inflammatory genes to ultimately eradicate infection and repair the damage. A disturbed balance between activation and inhibition of inflammatory pathways can set the stage for chronic inflammation which is increasingly recognized as a key pathogenic component of autoimmune, metabolic, cardiovascular and neurodegenerative disorders. Nuclear receptors (NRs) are a large family of transcription factors many of which are known for their potent anti-inflammatory actions. Activated by small lipophilic ligands, NRs interact with a wide range of transcription factors, cofactors and chromatin-modifying enzymes, assembling numerous cell- and tissue-specific DNA-protein transcriptional regulatory complexes with diverse activities. Here we discuss established and emerging roles and mechanisms by which NRs and, in particular, the glucocorticoid receptor (GR) repress genes encoding cytokines, chemokines and other pro-inflammatory mediators.

Indexed as

Transcription, GeneticAnimalsBase SequenceBinding SitesChemokinesConsensus SequenceEpigenesis, GeneticGlucocorticoidsHumansInflammationProtein BindingReceptors, Cytoplasmic and NuclearReceptors, GlucocorticoidChemokinesGlucocorticoidsReceptors, Cytoplasmic and NuclearReceptors, GlucocorticoidGlucocorticoid receptorInflammationNuclear receptorsTranscriptional repression

Identifiers

PMID23623868
PMCPMC3787948
OpenAlexW1983191249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.